A New York doctor received a seven-year prison sentence and over $2.2 million restitution for a $24 million Medicare fraud scheme involving kickbacks for unnecessary lab tests and orthotic braces. The case highlights federal enforcement efforts against healthcare fraud.
Indian national sentenced to two years for Medicare fraud involving fake COVID-19 testing claims totaling over $1.17 million. The case highlights ongoing challenges in health care fraud detection and regulatory compliance.
Patrick C. Moore Jr. sentenced to 46 months and $7.2M restitution for Medicare genetic testing kickback fraud. DOJ and HHS-OIG enforcement highlights healthcare fraud risks.
The DOJ sues Inland Empire Health Plan for allegedly misusing $320 million in federal Medicaid surplus funds, highlighting compliance challenges in managed care programs.
Health First Urgent Care agrees to $2.8 million settlement for Medicare and Medicaid overbilling linked to improper diagnostic test billing practices in Washington State.
A Massachusetts court awarded attorneys' fees to FCA defendants after finding relator engaged in fraudulent conduct by ordering unnecessary PCR tests to support whistleblower claims under the False Claims Act.
Trump administration proposes a Medicare and Medicaid pilot to cover GLP-1 weight loss drugs, highlighting access benefits alongside fraud and regulatory oversight challenges.
Krishna Gidwani pleaded guilty to conspiracy in a $4M Medicare fraud involving durable medical equipment. Part of DOJ's 2025 National Health Care Fraud Takedown.
The DOJ is investigating UnitedHealth Group's Medicare billing practices, focusing on diagnostic coding and in-home evaluations that may have led to inflated government payments. This probe highlights compliance and regulatory risks in Medicare Advantage programs.
Eye Consultants of Pennsylvania agrees to $790,000 settlement over False Claims Act violations involving Medicare E&M billing irregularities. Federal enforcement underscores commitment to Medicare compliance.
